Works matching IS 00093157 AND DT 2023 AND VI 68 AND IP 1

Results: 8

Front & Back Matter.

Published in:: Chemotherapy (0009-3157), 2023, v. 68, n. 1, p. 1, doi. 10.1159/000529468
Publication type:: Article

Fulminant Type 1 Diabetes Mellitus Caused by Long-Term Nivolumab Administration Followed by Nivolumab plus Cabozantinib Combination.

Published in:

Chemotherapy (0009-3157), 2023, v. 68, n. 1, p. 44, doi. 10.1159/000527541

By:

Homma, Takamasa;
Yoshida, Norio;
Tanaka, Kuniaki;
Isemura, Masaya;
Torii, Shota;
Kinoshita, Teruhisa;
Esaki, Hideki;
Sakakibara, Takashi;
Takimoto, Norio

Publication type:

Article

SARS-CoV-2 Infection in Patients Treated with Azacitidine and Venetoclax for Acute Leukemia: A Report of a Case Series Treated in a Single Institution.

Published in:

Chemotherapy (0009-3157), 2023, v. 68, n. 1, p. 16, doi. 10.1159/000527010

By:

Drozd-Sokołowska, Joanna;
Mądry, Krzysztof;
Barankiewicz, Joanna;
Kobylińska, Katarzyna;
Biecek, Przemysław;
Rytel, Jagoda;
Karakulska-Prystupiuk, Ewa;
Skwierawska, Kamila;
Salomon-Perzyński, Aleksander;
Stokłosa, Tomasz;
Basak, Grzegorz Władysław

Publication type:

Article

MIC Discrepancies between Parenteral and Oral Anti-Staphylococcal Beta-Lactams among MSSA.

Published in:

Chemotherapy (0009-3157), 2023, v. 68, n. 1, p. 55, doi. 10.1159/000526630

By:

Hernandez, Brandy N.;
Dilworth, Thomas;
Kesner, Jacob;
Ryan, Keenan;
Thelen, Haedi;
Mercier, Renée-Claude

Publication type:

Article

Does the Timing of Eribulin Treatment for Advanced or Metastatic Breast Cancer Matter? Evidence from a Real-World Setting.

Published in:

Chemotherapy (0009-3157), 2023, v. 68, n. 1, p. 23, doi. 10.1159/000526490

By:

Chen, Chih-Jung;
Nguyen, Hanh T.H.;
Huang, Chih-Hao;
Wang, Hwei-Chung;
Wu, Chen-Teng;
Wu, Yao-Chung;
He, Geng-Yan;
Chou, Chiahung;
Lin, Hsiang-Wen;
Liu, Liang-Chih

Publication type:

Article

Fusidic Acid and Its Major Active Metabolite Penetration into Cerebrospinal Fluid for Assessing Treatment of Intracranial Infections.

Published in:

Chemotherapy (0009-3157), 2023, v. 68, n. 1, p. 48, doi. 10.1159/000525906

By:

Rao, Zhi;
He, Zhong-fang;
Zheng, Mao-hua;
Dang, Zi-long;
Yang, Gang;
Zhang, Yong-hong;
Lu, Ning;
Wei, Yu-hui

Publication type:

Article

Treatment Tolerance of Cetuximab versus Alternative Chemotherapy Agents in Non-Cisplatin Candidates with Head and Neck Cancer Receiving Concurrent Chemoradiotherapy.

Published in:

Chemotherapy (0009-3157), 2023, v. 68, n. 1, p. 35, doi. 10.1159/000525481

By:

Morse, Ryan T.;
Ganju, Rohit G.;
Neeranjun, Rishi;
Gan, Gregory N.;
Cao, Ying;
Neupane, Prakash;
Kakarala, Kiran;
Shnayder, Yelizaveta;
Lominska, Christopher E.

Publication type:

Article

Risk of Immune-Related Pneumonitis with PD-1/PD-L1 Inhibitors in Different Cancer Types and Treatment Regimens: A Systematic Review and Meta-Analysis of 22 Randomized Controlled Trials.

Published in:

Chemotherapy (0009-3157), 2023, v. 68, n. 1, p. 1, doi. 10.1159/000523904

By:

Han, Lei;
Li, Guangxin;
Li, Huihui;
Zhao, Lei

Publication type:

Article